Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2017 pubmed 27 citations

Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology.

Mansbach. Jonathan M JM; Hasegawa. Kohei K; Ajami. Nadim J NJ; Petrosino. Joseph F JF; Piedra. Pedro A PA; Tierney. Courtney N CN; Espinola. Janice A JA; Camargo. Carlos A CA

Key Findings

  • Infants in the lowest LL‑37 quartile had a higher chance of intensive care use (aORā€Æā‰ˆā€Æ2)
  • Lower LL‑37 levels were associated with longer hospital stays
  • Low LL‑37 was linked to RSV infection, whereas higher LL‑37 was linked to rhinovirus

Practical Outcomes

  • The study suggests that LL‑37 levels reflect how severe bronchiolitis can get, especially with RSV. While it hints that boosting LL‑37 might help, there’s no direct evidence or protocol for supplementation in adults or biohackers yet. For now, it’s mainly a biomarker insight rather than an actionable intervention.

Summary

In a big study of over a thousand babies with bronchiolitis, kids with the lowest blood levels of the immune peptide LL‑37 were almost twice as likely to need intensive care and stayed in the hospital longer. Low LL‑37 also showed a strong link to infection by RSV, the most common cause of bronchiolitis, while higher LL‑37 was tied to the less severe rhinovirus.

Abstract

LL-37 is a host defense peptide with antimicrobial and immunomodulatory properties. We examined the relation of serum LL-37 levels to the severity of bronchiolitis and viral etiology. We performed a 17-center prospective cohort study in infants hospitalized with bronchiolitis over 3 winters (2011-2014). Site teams collected clinical data, nasopharyngeal aspirates and serum. We used real-time polymerase chain reaction to test nasopharyngeal aspirates for 16 viruses. We tested serum for LL-37. Severity of bronchiolitis was defined by intensive care use and hospital length of stay. Viral etiology was defined as respiratory syncytial virus (RSV) or rhinovirus (RV), including coinfections with other viruses. The median age of the 1005 enrolled infants was 3 months (interquartile range, 2-6 months). After adjustment for 12 variables, LL-37 levels in the lowest quartile, compared with the highest, were associated both with intensive care use (adjusted odds ratio [aOR], 1.97; P = .01) and longer hospital stay (1.34; P < .001). In separate multivariable models, infants with LL-37 levels in the lowest 3 quartiles, compared with the highest, were more likely to have RSV (eg, aOR, 2.6 [lowest quartile]; P < .001 [all quartiles]). By contrast, infants with the lowest 3 LL-37 quartiles were less likely to have RV (eg, aOR, 0.5 [lowest quartile]; Pall quartiles ≤ .03 [all quartiles]). In a large multicenter study of infants hospitalized with bronchiolitis, lower levels of serum LL-37 were associated with increased severity of illness. There was also an inverse relationship between LL-37 levels and the most common virus causing bronchiolitis, RSV. These findings highlight the role of LL-37 in the pathogenesis of bronchiolitis.

Study Information

Provider

pubmed

Year

2017

Date

2017-09-15T00:00:00.000Z

DOI

10.1093/cid/cix483

Citations

27

References

38